
Cooper Rice-Brading Foundation
202 posts

Cooper Rice-Brading Foundation
@coopsfoundation
Preserving Cooper’s legacy by generating critical funding for sarcoma research; promoting awareness & early diagnosis; and supporting patients & families






Afamicel, TCR targeting MAGEA-4 approved for #synovial sarcoma. A remarkable advancement for our patients, laying the foundation for future efforts in solid tumors. businesswire.com/news/home/2024…




We’re pleased to announce that Professor David Thomas, Head of the Genomic Cancer Medicine Lab at Garvan, has received the Australian and New Zealand Sarcoma Association Outstanding Contribution Award.




Really happy to see @ballingermandy receive the 2023 Liddy Shriver Early Research Award for her pioneering work over more than 15 years in sarcoma genetics and early detection to protect people with Li Fraumeni Syndrome. @GarvanInstitute @UNSWMedicine @OmicoAustralia







Here's what you need to know about our landmark initiative PrOSPeCT, which formally launched today 🧬 [1/6]

July is #SarcomaAwarenessMonth. One of the 'forgotten cancers', this rare form of cancer has multiple subtypes and can be difficult to diagnose accurately. At Omico, we drive research that will help enable earlier detection and improved outcomes for people with #sarcoma
